The theoretical 3-8% additional weight loss from adding cagrilintide to tirzepatide doesn't justify the significantly amplified side effects, 2-3x higher cost ($1,200-2,400 monthly), lack of physician support for experimental protocols, and unknown long-term safety profile
Additional risks to be aware of with Wegovy include pancreatitis and gallbladder disease
BPC-157 has shown strong results in tendon and ligament healing in rodent models accelerating repair and potentially reducing the extent of surgical intervention needed
Chang, F.C
The mice that ate only during the active 8 hours of their 24-hour cycle, however, not only avoided the development of new fatty deposits but reversed it, improving their liver health
This reduction in caloric intake can make it harder to meet their nutritional needs especially for protein, fats, fibre, vitamins and minerals